This is the artifact of H$^2$-LLM's dataflow exploration framwork, which contains the implementation of both compute-centric dataflow exploration in SpecPIM (ASPLOS '24) and data-centric dataflow ...

Boehringer Ingelheim is preparing for multiple drug launches in the second half of 2025, following strong first-half financial results that saw the company report a 6.3%* rise in group net sales ...